{"disease":{"id":"molecular-mechanisms-of-pharmacological-action","name":"molecular mechanisms of pharmacological action"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06535568","title":"Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)","phase":"NA","overall_status":"RECRUITING","enrollment_count":576,"lead_sponsor_name":"Fondazione Ricerca e Innovazione Cardiovascolare ETS","has_results":false},{"nct_id":"NCT06462196","title":"Natural History of Depression, Bipolar Disorder and Suicide Risk","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT04922593","title":"Relative Bioavailability of LY03010 Compared to Listed Drug","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":281,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT03889626","title":"The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":242,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05321602","title":"Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT03646292","title":"Antidiabetic Drugs for Steatotic Liver Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT04572451","title":"Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Yana Najjar","has_results":false},{"nct_id":"NCT03572790","title":"Effects of Seven Day Prucalopride Administration in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT06511908","title":"Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT03655847","title":"Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"Second Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT03841292","title":"Using Non-invasive Brain Stimulation (tDCS) With Varenicline for Treating Tobacco Dependence","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT03863366","title":"Effects of Acute Prucalopride Administration in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04556071","title":"Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"Xiaoxiang Chen","has_results":false},{"nct_id":"NCT04518852","title":"TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT04161404","title":"Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":18,"lead_sponsor_name":"University of Malaya","has_results":false},{"nct_id":"NCT05657860","title":"Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Maimonides Medical Center","has_results":false},{"nct_id":"NCT03403777","title":"Avelumab in Refractory Testicular Germ Cell Cancer.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"National Cancer Institute, Slovakia","has_results":false},{"nct_id":"NCT03107013","title":"A Study to Investigate the Mass Balance of BTD-001","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Balance Therapeutics","has_results":false},{"nct_id":"NCT04489420","title":"Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Celularity Incorporated","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}